The diagnosis of hereditary angioedema (HAE) is based on clinical suspicion and the existence of a family history, and requires confirmation through the complement study (C4, C1q, C1 inhibitor, and functional C1 inhibitor) and the SERPING1 gene study [8, 9]. This evidence concerns the gene C4A and hereditary angioedema.